Skip to content

Bausch Health Companies BHC Total Cost of Revenue

Total Cost of Revenue at other companies

PBH
Prestige Consumer HealthcarePBH
$135.32M+7.0%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$8.11B+10.2%
AbbVie logo
AbbVieABBV
$4.22B+5.4%
Organon logo
OrganonOGN
$677M+0.7%
HRO
HarrowHROW
$17.16M+10.5%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$13.8M+50.0%

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$1.79B-15.9%
Enterprise value$21.24B-5.6%
P/S0.2×0.0×

Profitability

See full
Gross margin71.4%
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%
Debt / equity45.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsSold.

The official record: Bausch Health Companies’s 10-Q, filed August 7, 2018, on SEC EDGAR. View the filing →

Questions, answered.

What does total cost of revenue mean?
The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.